Latest news with #AnnualGeneralShareholders'Meeting
Business Wire
07-05-2025
- Business
- Business Wire
1st Quarter Results
MADRID--( BUSINESS WIRE )-- Borja Acha Besga Secretary of the Board of Directors Madrid, 28 March 2025 OTHER RELEVANT INFORMATION In accordance with the provisions of Article 227 of the Spanish Securities Market Act, Endesa, S.A. hereby issues the Annual General Shareholders' Meeting notice and proposed resolutions: This English-language version has been translated from the original issued in Spanish by the entity itself and under its sole responsibility and is not considered official or regulat...
Yahoo
06-05-2025
- Business
- Yahoo
Outcome of Syensqo's 2025 Annual General Meeting
Syensqo SA Outcome of Syensqo's 2025 Annual General Meeting Brussels, Belgium – May 6, 2025 - 17:45 CEST Syensqo held its Annual General Shareholders' Meeting today. Shareholders voted in favor of all the resolutions proposed. Rosemary Thorne, Chair of the Board of Directors, reflected on the company's first full year post-demerger, highlighting strategic initiatives undertaken in 2024 to strengthen its foundation amid macroeconomic uncertainties. Key initiatives included cost controls, capacity investments, a share buyback, and increased employee shareholding. Ilham Kadri, CEO, celebrated Syensqo's teams who are at the heart of the company's growth, innovation and sustainability ambitions. Shareholders' support was evidenced by high level of approval for all resolutions, including: Approval of the 2024 financial statements Approval of a gross dividend of €1.62 per share payable on 19 May 2025 Approval of the 2024 remuneration report Visit the Shareholders' Meeting dedicated page for more details. Contacts Investors & Analysts Media Sherief Bakr Bisser Alexandrov Loïc Flament Robbin Moore-Randolph +44 7920 575 989 +33 607 635 280 +32 478 69 74 20 +1 470 493 2433 Perrine Marchal Laetitia Schreiber +32 478 32 62 72 +32 487 74 38 07 About Syensqo Syensqo is a science company developing groundbreaking solutions that enhance the way we live, work, travel and play. Inspired by the scientific councils which Ernest Solvay initiated in 1911, we bring great minds together to push the limits of science and innovation for the benefit of our customers, with a diverse, global team of more than 13,000 associates. Our solutions contribute to safer, cleaner, and more sustainable products found in homes, food and consumer goods, planes, cars, batteries, smart devices and health care applications. Our innovation power enables us to deliver on the ambition of a circular economy and explore breakthrough technologies that advance humanity. Investor Relations sources Attachment
Yahoo
07-04-2025
- Business
- Yahoo
Rexel - Combined Shareholders' Meeting of April 29, 2025
COMBINED SHAREHOLDERS' MEETINGOF APRIL 29, 2025 Rexel informs its shareholders that its Combined Shareholders' Meeting (ordinary and extraordinary) will be held on April 29, 2025, at 10:30 a.m. at Châteauform' City George V, 28, avenue George V, 75008 Paris. The prior notice of meeting ('avis de réunion') was published in the Bulletin des annonces légales obligatoires (BALO), dated Friday, March 21, 2025 (Bulletin des Annonces Légales Obligatoires), bulletin No. 35 (reference number 2500694). It contains the detailed agenda for the meeting and the draft resolutions and describes how shareholders can take part in and vote at the meeting. The convening notice for shareholders ('avis de convocation') will be published in the Bulletin des annonces légales obligatoires (BALO) of Friday, April 11, 2025, and in Journal Spécial des Sociétés of the same day. The convening notice has also been sent to shareholders whose shares are held in registered form and has been made available to the accredited banks or brokers for the shareholders whose shares are held in bearer form. In accordance with applicable laws and regulations, the information and documents relating to this meeting will be: made available on Rexel's website ( under the "Investors/Events/2025 Annual General Shareholders' Meeting" section; made available at Rexel's registered headquarters (13, boulevard du Fort de Vaux, 75017 Paris, France) and sent to shareholders by Société Générale Securities Services – Services Assemblées, CS 30812, 44308 Nantes Cedex 3, upon receipt of a request. Further information on this shareholders' meeting and more specifically on the shareholder voting procedures is available on the website ("Participating in the Annual Shareholders' Meeting"). ABOUT REXEL GROUP Rexel, worldwide expert in the multichannel professional distribution of products and services for the energy world, addresses three main markets: residential, commercial, and industrial. The Group supports its residential, commercial, and industrial customers by providing a tailored and scalable range of products and services in energy management for construction, renovation, production, and maintenance. Rexel operates through a network of more than 1,950 branches in 18 countries, with more than 27,000 employees. The Group's sales were €19.3 billion in 2024. Rexel is listed on the Eurolist market of Euronext Paris (compartment A, ticker RXL, ISIN code FR0010451203). It is included in the following indices: MSCI World, CAC Next 20, SBF 120, CAC Large 60, CAC 40 ESG, CAC SBT 1.5 NR, CAC AllTrade, CAC AllShares, FTSE EuroMid, and STOXX600. Rexel is also part of the following SRI indices: FTSE4Good, Dow Jones Sustainability Index Europe, Euronext Vigeo Europe 120 and Eurozone 120, STOXX® Global ESG Environmental Leaders, and S&P Global Sustainability Yearbook 2022, in recognition of its performance in terms of Corporate Social Responsibility (CSR). For more information, visit CONTACTSFINANCIAL ANALYSTS/INVESTORS Ludovic DEBAILLEUX +33 1 42 85 76 12 PRESSE Brunswick: Laurence FROST +33 6 31 65 57 06 lfrost@ Attachment PR_Shareholders'meeting 2025.04.29Sign in to access your portfolio
Yahoo
30-01-2025
- Business
- Yahoo
Takeda announces appointment of Julie Kim as CEO
Takeda has announced the appointment of Julie Kim as successor to Christophe Weber, its current president, CEO and representative director, effective from June 2026. The decision was unanimously reached by Takeda's board of directors. Kim, the current president of the company's US Business Unit, will be proposed as a candidate for election to the board at the Annual General Shareholders' Meeting to be held in June 2026. Following his retirement, Weber will not maintain a board seat at the company. Kim has been with the company since 2019 as a member of the executive team and took charge of the business unit in 2022. Her healthcare career spans three decades, with senior roles across general management, marketing and international market access. Her experience extends to working with therapeutic areas. Kim said: 'I am excited to guide Takeda through the next phase, together with our exceptional and talented people, while staying true to our strong culture that is rooted in our values and shaped by a heritage of more than 240 years. 'I want to thank the board of directors for their confidence in me. I look forward to working with the board, Takeda's executive team and all colleagues to serve and create long-term value for patients, shareholders and society.' Christophe Weber joined as chief operating officer of Takeda in April 2014. He rose to become president and representative director in June 2014, and CEO in April 2015. His tenure at the company has been marked by a strategic emphasis on globalisation, research and development, and the cultivation of a diverse and inclusive workplace. In a significant move towards sustainability, Takeda announced a partnership with Boston Medical Center, in October 2024. This collaboration is focused on advancing decarbonisation initiatives within the US healthcare sector. "Takeda announces appointment of Julie Kim as CEO" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
